We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+47.43%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$540M
AUM Growth
+$30.8M
(+6%)
Cap. Flow
-$71M
Cap. Flow
% of AUM
-13.15%
Top 10 Holdings %
Top 10 Hldgs %
9.77%
Holding
405
New
161
Increased
21
Reduced
59
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Digital
APLD
|
+$4.62M |
| 2 |
WW
WW International
WW
|
+$3.97M |
| 3 |
Harmonic Inc
HLIT
|
+$3.58M |
| 4 |
SI-BONE Inc
SIBN
|
+$3.34M |
| 5 |
Tactile Systems Technology
TCMD
|
+$2.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viking Therapeutics
VKTX
|
+$5.66M |
| 2 |
Harrow
HROW
|
+$5.57M |
| 3 |
Impinj
PI
|
+$5.06M |
| 4 |
Ceco Environmental
CECO
|
+$4.79M |
| 5 |
Par Pacific Holdings
PARR
|
+$4.38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.89% |
| 2 | Technology | 25.18% |
| 3 | Industrials | 23.68% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Consumer Staples | 3.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Kratos Defense & Security Solutions
KTOS
$10.8B
| $1.09M | 0.2% |
+76,067
| New | +$1.03M |
|
227
nLIGHT
LASR
$4.26B
| $1.08M | 0.2% |
+70,308
| New | +$859K |
|
|
228
Harrow
HROW
$1.49B
| $1.08M | 0.2% |
56,806
-253,128
| -82% | -$5.57M |
|
|
NOA
229
North American Construction
NOA
$393M
| $1.08M | 0.2% |
+56,327
| New | +$1.06M |
|
230
Gibraltar Industries
ROCK
$1.51B
| $1.08M | 0.2% |
+17,150
| New | +$927K |
|
231
CleanSpark
CLSK
$3.27B
| $1.07M | 0.2% |
+249,273
| New | +$1M |
|
232
MoonLake Immunotherapeutics
MLTX
$1.53B
| $1.07M | 0.2% |
+20,917
| New | +$563K |
|
|
ZUO
233
DELISTED
Zuora, Inc.
ZUO
| $1.06M | 0.2% |
+96,799
| New | +$917K |
|
234
Vericel Corp
VCEL
$2.29B
| $1.06M | 0.2% |
+28,235
| New | +$928K |
|
235
Viemed Healthcare
VMD
$363M
| $1.06M | 0.2% |
108,371
-139,632
| -56% | -$1.42M |
|
236
Black Diamond Therapeutics
BDTX
$110M
| $1.05M | 0.19% |
+207,428
| New | +$424K |
|
237
Coda Octopus Group
CODA
$119M
| $1.01M | 0.19% |
+123,262
| New | +$1.07M |
|
238
Perma-Fix Environmental Services
PESI
$377M
| $996K | 0.18% |
90,708
-39,213
| -30% | -$409K |
|
|
INZY
239
DELISTED
Inozyme Pharma
INZY
| $982K | 0.18% |
+176,228
| New | +$1.04M |
|
240
Carpenter Technology
CRS
$27.7B
| $963K | 0.18% |
17,149
-38,339
| -69% | -$1.88M |
|
241
GSI Technology
GSIT
$254M
| $953K | 0.18% |
+172,246
| New | +$748K |
|
242
Cellebrite
CLBT
$3.86B
| $950K | 0.18% |
+131,950
| New | +$769K |
|
243
AvePoint
AVPT
$2.71B
| $930K | 0.17% |
+161,534
| New | +$851K |
|
244
Delcath Systems
DCTH
$534M
| $905K | 0.17% |
+155,280
| New | +$973K |
|
245
Intapp
INTA
$2.8B
| $871K | 0.16% |
20,777
-74,355
| -78% | -$3.21M |
|
246
IDEAYA Biosciences
IDYA
$3.49B
| $831K | 0.15% |
+35,363
| New | +$727K |
|
247
Nano X Imaging
NNOX
$71M
| $811K | 0.15% |
+52,385
| New | +$726K |
|
|
CHUY
248
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $808K | 0.15% |
19,805
-15,708
| -44% | -$585K |
|
249
Vicor
VICR
$10.1B
| $796K | 0.15% |
+14,748
| New | +$728K |
|
250
CBIZ
CBZ
$2.96B
| $770K | 0.14% |
14,457
-31,075
| -68% | -$1.6M |
|
Similar funds
RWM
MCM
HP
OMG
ICCFIA
WFAL
WCM
TSS
EAM Investors's Q2 2023 Portfolio in Review
As of Q2 2023, EAM Investors held 405 positions worth $540M, up 6% from $509M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
EAM Investors withdrew a net $71M in Q2 2023, closing 149 positions and reducing 59 holdings. Its most notable exit was Viking Therapeutics, an estimated $5.66M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.
Against the trend, EAM Investors opened a new position in Applied Digital worth $7.24M.
- EAM Investors's largest Q2 2023 buy was Applied Digital: 774,423 shares worth $7.24M.
- EAM Investors added most to Arlo Technologies in Q2 2023, an estimated $2.35M increase.
- EAM Investors's biggest Q2 2023 reduction was Harrow, cutting an estimated $5.57M.
- EAM Investors fully exited Viking Therapeutics in Q2 2023, selling an estimated $5.66M.
- EAM Investors's ten largest holdings make up 9.8% of its $540M portfolio in Q2 2023.
- EAM Investors opened 161 new positions and closed 149 in Q2 2023.
- EAM Investors's portfolio value rose 6% quarter-over-quarter to $540M.
Based on EAM Investors's 13F filing for Q2 2023, filed 11 Aug 2023.